Skip to main content

News and Press Releases

Johns Hopkins University Protocol IRB00124162: A Phase 2 Randomized, Double-Blind, Placebo Controlled Crossover Trial to Evaluate The Safety, Tolerability, And Efficacy Of Subcutaneous Injections Of Elamipretide (Mtp - 131) In Subjects With Genetically Co

If you or your child is 12 years of age or older and has Barth syndrome, and you are interested in learning about a research study about an investigational treatment for Barth syndrome, please contact Dr. Hilary Vernon, MD PhD via e-mail at or at her office at 410-502-8625.

Powered by Firespring